Author

Lauren Lowell

Lauren Lowell designs early drug trials at a contract research organization in Wilmington, Delaware. Working as a preclinical pharmacology scientist, she sets up in vitro and rodent studies for pharmaceutical developers, with a focus on receptor interactions and cellular responses. Lowell received a bachelor’s in pharmacology and an MS in pharmacology from the University of Montana. Her projects examine how novel chemical candidates bind to biological targets before clinical trials.

The Different Types of Opioid Receptors and Their Functions
What Is Anisomycin and How Is It Used in Research?
Phosphodiesterases: Function, Types, and Drug Targets
Phenotypic Drug Discovery: Current Approaches & Insights
What Is Structure-Based Drug Design?
What Is the Mu Opioid Receptor and How Does It Work?
p38 MAPK Inhibitors: Mechanism and Therapeutic Uses
What Is an Nrf2 Inhibitor and How Does It Work?
What Are DYRK1A Inhibitors and How Do They Work?
What Is Rational Drug Design and How Does It Work?
What Is Target Identification in Drug Discovery?
MG132 Proteasome Inhibitor: What It Is & How It Works
What Is the Hit-to-Lead Process in Drug Discovery?
Bafilomycin A1: Mechanism, Effects, and Research Uses
Delta Receptors: Function, Therapeutic Use, and Risks
Calpain Inhibitor: Function, Uses, and Research
Orphan GPCRs: A Frontier in Drug Discovery
Liproxstatin-1: Ferroptosis Inhibition for Cellular Health
How VX765 Targets Caspase-1 to Influence Inflammatory Pathways
Caspase 3 Inhibitor: Mechanisms, Types, and Relevance
Small Molecule Drug Discovery: Advancing Therapeutics
How Long Does Ketamine Neuroplasticity Last in the Brain?
Effexor and LSD: Are There Shared Neurochemical Pathways?